Evidence map›Paper›PMID 41760661›Full record

ArticleNature communications2026

Dysregulation of the DNA damage response by phosphorothioate antisense oligonucleotides.

Linn Hjelmgren, Qianyu Zhou, Sandro Schmidli, Manon Gloudemans, Tomasz Czapik, Samantha Roudi, Malgorzata Honcharenko, Daniel W Hagey, Samir El Andaloussi, Marianne Farnebo

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Linn HjelmgrenDepartment of Oncology and Pathology, Karolinska Institutet, Solna, Sweden.ORCID 0009-0005-9133-6531
Qianyu ZhouDepartment of Oncology and Pathology, Karolinska Institutet, Solna, Sweden.
Sandro SchmidliDepartment of Oncology and Pathology, Karolinska Institutet, Solna, Sweden.ORCID 0000-0001-6538-3581
Manon GloudemansDepartment of Oncology and Pathology, Karolinska Institutet, Solna, Sweden.ORCID 0009-0006-0482-3356
Tomasz CzapikDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-8124-1003
Samantha RoudiDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0003-3923-3410
Malgorzata HoncharenkoDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Daniel W HageyDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0001-9246-6235
Samir El AndaloussiDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0003-4468-9113
Marianne FarneboDepartment of Oncology and Pathology, Karolinska Institutet, Solna, Sweden. marianne.farnebo@ki.se.ORCID 0000-0002-2677-558X

Funding

Novo Nordisk FoundationSwedish Cancer SocietySwedish Research Council
6 · The paper itself

Abstract

Phosphorothioate (PS)-modified antisense oligonucleotides (ASOs) are widely used to modulate gene expression in basic research and therapy. Within cells, these ASOs seed nuclear structures with unclear functions and consequences. At DNA breaks, endogenous nucleotide polymers drive the assembly of biomolecular condensates that recruit repair proteins, but the underlying mechanism(s) and effects on repair enzyme activation are poorly understood. Here, we show that ASOs bind to DNA-PKcs, ATM, and PARP1, triggering phase separation and formation of nuclear condensates containing ASOs and these essential repair enzymes. Condensates assembly is stimulated by ASO concentration and ATM activity, while limited by DNA-PKcs activity. Notably, these condensates become enzymatically active and erroneously elicit the DNA damage response in the absence of DNA damage, activating cell cycle checkpoints, disturbing endogenous repair and causing accumulation of toxic DNA lesions. These findings uncover mechanisms for ASO toxicity and the activation of DNA repair enzymes by nucleotide polymers.

Indexed as

DNA DamageDNA RepairOligonucleotides, AntisensePhosphorothioate OligonucleotidesAnimalsAtaxia Telangiectasia Mutated ProteinsCell Cycle CheckpointsCell NucleusDNA-Activated Protein KinaseHumansPhase SeparationPoly (ADP-Ribose) Polymerase-1Ataxia Telangiectasia Mutated ProteinsDNA-Activated Protein KinaseOligonucleotides, AntisensePARP1 protein, humanPhosphorothioate OligonucleotidesPoly (ADP-Ribose) Polymerase-1

Identifiers

PMID41760661
PMCPMC12954066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.